Sinocare Inc. (SHE:300298)
China · Delayed Price · Currency is CNY 14.84
-0.26 (-1.72%)
Jun 4, 2026, 3:04 PM CST
Sinocare Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 4,855 | 4,657 | 4,428 | 4,043 | 3,936 | 2,344 |
Other Revenue | 2.3 | 2.3 | 15.22 | 15.66 | 16.53 | 17.01 |
| 4,857 | 4,659 | 4,443 | 4,059 | 3,952 | 2,361 | |
Revenue Growth (YoY) | 8.63% | 4.87% | 9.47% | 2.69% | 67.38% | 17.17% |
Cost of Revenue | 2,477 | 2,423 | 2,026 | 1,909 | 1,899 | 975.44 |
Gross Profit | 2,380 | 2,236 | 2,417 | 2,150 | 2,054 | 1,386 |
Selling, General & Admin | 1,790 | 1,715 | 1,597 | 1,399 | 1,325 | 903.08 |
Research & Development | 262.49 | 274.63 | 375 | 356.41 | 306.31 | 182.43 |
Other Operating Expenses | 46.64 | 16.32 | -18.64 | -26.79 | -6.49 | -24.7 |
Operating Expenses | 2,110 | 1,991 | 1,983 | 1,740 | 1,635 | 1,129 |
Operating Income | 269.96 | 244.94 | 434.09 | 409.5 | 418.65 | 256.76 |
Interest Expense | -38.1 | -38.88 | -47.47 | -66.28 | -67.74 | -27.71 |
Interest & Investment Income | 21.81 | 22.96 | 20.51 | 18.66 | 12.18 | 10.6 |
Currency Exchange Gain (Loss) | -12.59 | -12.59 | 12.32 | 9.99 | 25.79 | -11.09 |
Other Non Operating Income (Expenses) | -35.02 | -30.87 | -4.38 | -39.46 | 156.67 | -7.39 |
EBT Excluding Unusual Items | 206.06 | 185.56 | 415.07 | 332.4 | 545.55 | 221.17 |
Impairment of Goodwill | -144.56 | -144.56 | - | -84.23 | -6.94 | -4.37 |
Gain (Loss) on Sale of Investments | -3.24 | -3.7 | -33.27 | - | - | -80.5 |
Gain (Loss) on Sale of Assets | -1.19 | -1.14 | 0.96 | -6 | -0.64 | 0.12 |
Asset Writedown | -0.34 | - | -21.51 | -8.86 | -16.3 | -11.39 |
Legal Settlements | 12.55 | 12.55 | -0.5 | - | - | - |
Other Unusual Items | 32.13 | 25.35 | 34.52 | 15.26 | 16.98 | 13.14 |
Pretax Income | 101.4 | 74.05 | 395.26 | 248.56 | 538.64 | 138.18 |
Income Tax Expense | 57.7 | 51.98 | 49.41 | 52.72 | 47.95 | 31.16 |
Earnings From Continuing Operations | 43.71 | 22.08 | 345.85 | 195.85 | 490.69 | 107.01 |
Minority Interest in Earnings | 74.51 | 70.57 | -19.56 | 88.55 | -44.19 | 0.55 |
Net Income | 118.22 | 92.65 | 326.29 | 284.4 | 446.51 | 107.57 |
Net Income to Common | 118.22 | 92.65 | 326.29 | 284.4 | 446.51 | 107.57 |
Net Income Growth | -62.76% | -71.60% | 14.73% | -36.31% | 315.09% | -42.44% |
Shares Outstanding (Basic) | 547 | 550 | 554 | 557 | 558 | 561 |
Shares Outstanding (Diluted) | 547 | 550 | 554 | 557 | 558 | 561 |
Shares Change (YoY) | -1.18% | -0.74% | -0.52% | -0.24% | -0.57% | 0.36% |
EPS (Basic) | 0.22 | 0.17 | 0.59 | 0.51 | 0.80 | 0.19 |
EPS (Diluted) | 0.22 | 0.17 | 0.59 | 0.51 | 0.80 | 0.19 |
EPS Growth | -62.32% | -71.39% | 15.33% | -36.16% | 317.48% | -42.65% |
Free Cash Flow | 266.2 | 406.27 | 444.62 | 388.54 | 362.13 | 76.23 |
Free Cash Flow Per Share | 0.49 | 0.74 | 0.80 | 0.70 | 0.65 | 0.14 |
Dividend Per Share | - | - | 0.220 | 0.200 | 0.200 | 0.200 |
Dividend Growth | - | - | 10.00% | - | - | - |
Gross Margin | 48.99% | 47.99% | 54.40% | 52.96% | 51.96% | 58.69% |
Operating Margin | 5.56% | 5.26% | 9.77% | 10.09% | 10.59% | 10.87% |
Profit Margin | 2.43% | 1.99% | 7.34% | 7.01% | 11.30% | 4.55% |
Free Cash Flow Margin | 5.48% | 8.72% | 10.01% | 9.57% | 9.16% | 3.23% |
EBITDA | 428.47 | 411.83 | 634.48 | 599.23 | 584.42 | 353.78 |
EBITDA Margin | 8.82% | 8.84% | 14.28% | 14.76% | 14.79% | 14.98% |
D&A For EBITDA | 158.51 | 166.88 | 200.39 | 189.73 | 165.78 | 97.02 |
EBIT | 269.96 | 244.94 | 434.09 | 409.5 | 418.65 | 256.76 |
EBIT Margin | 5.56% | 5.26% | 9.77% | 10.09% | 10.59% | 10.87% |
Effective Tax Rate | 56.90% | 70.19% | 12.50% | 21.21% | 8.90% | 22.55% |
Revenue as Reported | 4,857 | 4,659 | 4,443 | 4,059 | 3,952 | - |
Advertising Expenses | - | 107.83 | 140.71 | 348.75 | 306.55 | 321.85 |